Evogene (EVGN) Stock Chart & Stock Price History $1.25 -0.02 (-1.19%) As of 01:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Evogene Stock Price Performance The Evogene (EVGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.55%, with a year-to-date return of -33.42%. In the past month, the stock has decreased 18.09%, reflecting recent market activity. As of the latest close, Evogene traded at $1.26 with a market cap of $6.76 million and volume of 165,522 shares. Five years ago, the stock traded at a split-adjusted price of $10.40, representing a 88.03% decrease over that period. At the time, it had a market cap of $26.78 million and a volume of 13,080 shares. Receive EVGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.12%1 Month Performance-18.09%3 Month Performance+25.06%Year-To-Date Performance-33.42%1 Year Performance-80.55%5 Year Performance-88.03% EVGN Stock Chart for Wednesday, July, 16, 2025 EVGN Chart by TradingView Evogene Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$1.25$1.26+0.80%$1.30$1.24165,522 shs$6.76 million07/14/2025$1.37$1.25-8.76%$1.34$1.25187,611 shs$6.71 million07/11/2025$1.45$1.37-5.52%$1.46$1.3569,396 shs$7.35 million07/10/2025$1.49$1.45-2.68%$1.48$1.4373,682 shs$7.79 million07/09/2025$1.41$1.49+5.67%$1.50$1.41164,519 shs$8.00 million07/08/2025$1.32$1.41+6.82%$1.46$1.36265,803 shs$7.57 million07/07/2025$1.36$1.32-2.94%$1.39$1.32167,663 shs$7.09 million07/04/2025$1.36$1.36$1.38$1.3444,787 shs$7.30 million07/03/2025$1.36$1.36$1.38$1.3444,787 shs$7.30 million07/02/2025$1.34$1.36+1.49%$1.40$1.33101,082 shs$7.30 million Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$1.28$1.34+4.69%$1.44$1.26136,289 shs$7.20 million06/30/2025$1.30$1.28-1.54%$1.34$1.28139,237 shs$6.87 million06/27/2025$1.28$1.30+1.56%$1.33$1.28111,473 shs$6.98 million06/26/2025$1.36$1.28-5.88%$1.37$1.27155,540 shs$6.87 million06/25/2025$1.40$1.36-2.86%$1.42$1.35127,144 shs$7.30 million06/24/2025$1.38$1.40+1.45%$1.44$1.39135,946 shs$7.52 million06/23/2025$1.46$1.38-5.48%$1.45$1.34197,175 shs$7.41 million06/20/2025$1.58$1.46-7.59%$1.57$1.40241,455 shs$7.84 million06/19/2025$1.58$1.58$1.62$1.52184,016 shs$8.49 million06/18/2025$1.57$1.58+0.64%$1.62$1.52184,016 shs$8.49 million06/17/2025$1.52$1.57+3.29%$1.63$1.46346,972 shs$8.42 million06/16/2025$1.38$1.52+10.14%$1.58$1.43623,230 shs$8.16 million Related Companies CARM Stock Chart TOMZ Stock Chart ENFY Stock Chart SDST Stock Chart SNES Stock Chart GURE Stock Chart CNEY Stock Chart NITO Stock Chart BSLK Stock Chart HGAS Stock Chart Receive EVGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EVGN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
